RADx℠ Tech/ATP Program

gloved hand holding a plastic test panel

Program Contacts

RADxSM Tech/ATP programmatic or technical inquiries:

All other RADxSM Tech/ATP Applicants:

SBIR/STTR Applicants:

All others: COVID19NIBIB@nibib.gov


The RADxSM Tech/ATP program is one component of the overarching RADxSM Initiative at NIH to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing.

NIH and POCTRN have suspended the RADxSM Fast-Track Program for COVID-19 Test Development and Distribution submission portal and are currently not accepting new applications. Those who have previously submitted complete applications that meet the eligibility criteria will be reviewed. If additional resources to support the RADxSM program become available, NIH and POCTRN may re-evaluate this decision and could consider accepting applications once again. In the meantime, those interested in the RADxSM program are encouraged to pursue other funding opportunities offered by NIH.


Summary data on proposals submitted to the RADx℠ Tech and ATP Programs. Data is updated weekly.

The RADxSM Tech and ATP programs are supporting late-stage development of innovative point-of-care, home-based tests, and clinical laboratory tests.

Information about studies to evaluate diagnostic tests being developed for COVID-19.

This webinar series hosted by POCTRN provides information on RADx Tech/ATP program activities.  Register for upcoming events or watch previous webinars.

Descriptions of governance and operational groups overseeing and implementing the RADxSM Tech program.

Answers to frequently asked questions about the RADxSM Tech Program.

The RADxSM Fast-Track Program for COVID-19 Test Development and Distribution has suspended the submission portal and is currently not accepting new applications.

COVID-19, RADx℠ in the News